rs121913010
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_001943.5(DSG2):c.2434G>A(p.Gly812Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000366 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G812C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001943.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001943.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DSG2 | NM_001943.5 | MANE Select | c.2434G>A | p.Gly812Ser | missense | Exon 15 of 15 | NP_001934.2 | ||
| DSG2-AS1 | NR_045216.1 | n.1432C>T | non_coding_transcript_exon | Exon 4 of 6 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DSG2 | ENST00000261590.13 | TSL:1 MANE Select | c.2434G>A | p.Gly812Ser | missense | Exon 15 of 15 | ENSP00000261590.8 | ||
| DSG2 | ENST00000713817.1 | c.2425G>A | p.Gly809Ser | missense | Exon 16 of 16 | ENSP00000519121.1 | |||
| DSG2 | ENST00000713819.1 | c.2425G>A | p.Gly809Ser | missense | Exon 17 of 17 | ENSP00000519123.1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152142Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000241 AC: 6AN: 249442 AF XY: 0.0000296 show subpopulations
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74316 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:3
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30615648, 25213555, 23911551, 27532257, 28567303, 26633542, 20708101, 28454995, 30847666, 32516855, 31402444)
Cardiomyopathy Uncertain:2
This missense variant replaces glycine with serine at codon 812 of the DSG2 protein. Computational prediction suggests that this variant may not impact protein structure and function. An experimental study has suggested that this variant does not cause significant loss of cell-cell cohesion in vitro (PMID: 25213555). This variant has been identified in four individuals affected with arrhythmogenic right ventricular cardiomyopathy in one family and was absent in five unaffected family members (PMID: 20708101). This variant has been reported in another six individuals affected with or suspected to be affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 27532257, 28454995, 28567303, 32114801, 36621286); in an individual affected with left ventricular noncompaction cardiomyopathy after pericarditis (PMID: 32516855); in an individual with unspecified cardiomyopathy (PMID: 30847666); and in a few exome-sequencing participants not selected for cardiomyopathy phenotype (PMID: 24055113, 26633542). This variant has also been identified in 11/280834 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
This missense variant replaces glycine with serine at codon 812 of the DSG2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). An experimental study has suggested that this variant does not cause significant loss of cell-cell cohesion in vitro (PMID: 25213555). This variant has been identified in four individuals affected with arrhythmogenic right ventricular cardiomyopathy in one family and absent in five unaffected family members (PMID: 20708101). This variant has been reported in another six individuals affected with or suspected of having arrhythmogenic right ventricular cardiomyopathy (PMID: 27532257, 28454995, 28567303, 32114801, 36621286), in an individual affected with left ventricular noncompaction cardiomyopathy after pericarditis (PMID: 32516855), in an individual with unspecified cardiomyopathy (PMID: 30847666), and in a few exome-sequencing participants not selected for cardiomyopathy phenotype (PMID: 24055113, 26633542). This variant has also been identified in 11/280834 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Arrhythmogenic right ventricular dysplasia 10 Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 812 of the DSG2 protein (p.Gly812Ser). This variant is present in population databases (rs121913010, gnomAD 0.009%). This missense change has been observed in individual(s) with DSG2-related conditions (PMID: 20031617, 20708101, 27532257, 28454995, 30847666, 32516855). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 199817). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt DSG2 protein function with a negative predictive value of 95%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on DSG2 function (PMID: 20708101, 25213555). This variant disrupts the p.Gly812 amino acid residue in DSG2. Other variant(s) that disrupt this residue have been observed in individuals with DSG2-related conditions (PMID: 16773573), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Hypertrophic cardiomyopathy Uncertain:1
ACMG: BS2
Cardiovascular phenotype Uncertain:1
The p.G812S variant (also known as c.2434G>A), located in coding exon 15 of the DSG2 gene, results from a G to A substitution at nucleotide position 2434. The glycine at codon 812 is replaced by serine, an amino acid with similar properties. This alteration has been reported in individuals with features consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC), but has also been detected in individuals without significant ARVC findings (Gehmlich K et al. Heart Rhythm, 2010 Oct;7:1446-53; Retterer K et al. Genet. Med., 2016 07;18:696-704; Stavropoulos DJ et al. NPJ Genom Med, 2016 Jan;1; Walsh R et al. Genet. Med., 2017 02;19:192-203;pers. comm.; Ambry internal data). This alteration was reported to segregate with disease in a family with ARVC; however, one young relative with a borderline ARVC diagnosis was negative for this variant (Gehmlich K et al, Heart Rhythm 2010 Oct; 7(10):1446-53). In vitro functional studies have not detected a negative impact on DSG2 function; however, these studies may not reflect in vivo function (Gehmlich K et al, Heart Rhythm 2010 Oct; 7(10):1446-53; Schlipp A et al. Cardiovasc. Res., 2014 Nov;104:245-5). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at